Loading...
Docoh

Vallon Pharmaceuticals (VLON)

News

From Benzinga Pro
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
25 May 22
Pre-Market Outlook, Markets, Movers
12 Health Care Stocks Moving In Tuesday's After-Market Session
24 May 22
Movers
Gainers
Stocks That Hit 52-Week Lows On Tuesday
24 May 22
News, Options, Intraday Update, Markets, Movers, Trading Ideas
On Tuesday, 540 companies set new 52-week lows.
73 Biggest Movers From Yesterday
17 May 22
News, Penny Stocks, Small Cap, Pre-Market Outlook, Markets, Movers, Trading Ideas
Gainers AgriFORCE Growing Systems Ltd. (NASDAQ: AGRI) shares jumped 65.9% to close at $2.77 on Monday after gaining around 10% on Friday.
Stocks That Hit 52-Week Lows On Monday
16 May 22
News, Options, Intraday Update, Markets, Movers, Trading Ideas
On Monday, 198 companies reached new 52-week lows.
The Week Ahead In Biotech: Gene & Cell Therapy Conference, Tapering Earnings News, OKYO Pharma IPO And More
16 May 22
Biotech, Earnings, News, IPOs, Trading Ideas, General
Biopharma stocks remained largely unchanged in the week ending May 13, with the defensive nature of the sector coming to its aid. Stocks reacted to the broader market move and earnings news from mid-cap companies.
30 Stocks Moving in Monday's Pre-Market Session
16 May 22
News, Penny Stocks, Small Cap, Pre-Market Outlook, Markets, Movers, Trading Ideas
Gainers AgriFORCE Growing Systems Ltd. (NASDAQ: AGRI) rose 25.2% to $2.09 in pre-market trading after gaining around 10% on Friday.
110 Biggest Movers From Friday
16 May 22
News, Penny Stocks, Small Cap, Pre-Market Outlook, Markets, Movers, Trading Ideas
Gainers ShiftPixy, Inc. (NASDAQ: PIXY) shares jumped 154.9% to close at $0.51. ShiftPixy reported board approval special dividend to shareholders in form of common shares of Industrial Human Capital.
12 Health Care Stocks Moving In Friday's Intraday Session
13 May 22
Intraday Update, Markets, Movers
Stocks That Hit 52-Week Lows On Friday
13 May 22
News, Options, Intraday Update, Markets, Movers, Trading Ideas
On Friday, 153 companies set new 52-week lows.
Vallon Pharmaceuticals Announces $3.9M Registered Direct Offering; 3.7M Shares At $1.0632/Share
13 May 22
News
Vallon Pharmaceuticals, Inc. (NASDAQ:VLON), (“Vallon” or the “Company”), a clinical-stage biopharmaceutical company primarily focused on the development of novel drugs that are designed to deter
Vallon Pharma Posts Additional Data From SEAL Study Of Formulated CNS Stimulant
12 May 22
Biotech, News, Penny Stocks, Health Care, General
Vallon Pharmaceuticals Reports Additional Pharmacokinetic And Pharmacodynamic Data From SEAL Study Of ADAIR
12 May 22
Biotech, General
Vallon Pharmaceuticals, Inc. (NASDAQ:VLON), (“Vallon” or the “Company”), a clinical-stage biopharmaceutical company primarily focused on the development of novel drugs that are designed to deter
12 Health Care Stocks Moving In Thursday's Pre-Market Session
12 May 22
Pre-Market Outlook, Markets, Movers
Vallon Pharma Reports Issued Japanese Patent Covering Composition Of Matter, Methods Of Manufacturing For ADAIR Abuse-Deterrent Formulation Of Immediate-Release Dextroamphetamine
11 May 22
Biotech, News, FDA, Legal, General
Vallon Pharmaceuticals, Inc. (NASDAQ:VLON), (“Vallon” or the “Company”), a clinical-stage biopharmaceutical company primarily focused on the development of novel drugs that are designed to deter
Vallon Pharmaceuticals Q1 Net Loss $2.6M
9 May 22
Earnings, News
Vallon Pharmaceuticals (NASDAQ:VLON) will report on Q1 2022.
71 Biggest Movers From Yesterday
27 Apr 22
News, Penny Stocks, Small Cap, Pre-Market Outlook, Markets, Movers, Trading Ideas
Gainers
12 Health Care Stocks Moving In Tuesday's Intraday Session
26 Apr 22
Intraday Update, Markets, Movers
60 Biggest Movers From Yesterday
26 Apr 22
News, Penny Stocks, Small Cap, Pre-Market Outlook, Markets, Movers, Trading Ideas
Gainers
12 Health Care Stocks Moving In Monday's Intraday Session
25 Apr 22
Intraday Update, Markets, Movers

Press releases

From Benzinga Pro
Vallon Pharmaceuticals Announces $3.9 Million Registered Direct Offering
13 May 22
Press Releases
PHILADELPHIA, PA, May 13, 2022 (GLOBE NEWSWIRE) -- Vallon Pharmaceuticals, Inc. (NASDAQ:VLON), ("Vallon" or the "Company"), a clinical-stage biopharmaceutical company primarily focused on the development of novel drugs
Vallon Pharmaceuticals Reports Additional Pharmacokinetic and Pharmacodynamic Data from SEAL Study of ADAIR
12 May 22
Press Releases
PHILADELPHIA, PA, May 12, 2022 (GLOBE NEWSWIRE) -- Vallon Pharmaceuticals, Inc. (NASDAQ:VLON), ("Vallon" or the "Company"), a clinical-stage biopharmaceutical company primarily focused on the development of novel drugs
Vallon Pharmaceuticals Announces Issuance of Japanese Patent Covering Composition of Matter and Methods of Manufacturing for ADAIR
11 May 22
Press Releases
PHILADELPHIA, PA, May 11, 2022 (GLOBE NEWSWIRE) -- Vallon Pharmaceuticals, Inc. (NASDAQ:VLON), ("Vallon" or the "Company"), a clinical-stage biopharmaceutical company primarily focused on the development of novel drugs
Vallon Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Corporate Update
9 May 22
Press Releases
PHILADELPHIA, PA, May 09, 2022 (GLOBE NEWSWIRE) -- Vallon Pharmaceuticals, Inc. (NASDAQ:VLON), ("Vallon" or the "Company"), a clinical-stage biopharmaceutical company primarily focused on the development of novel drugs
Thinking about buying stock in Vallon Pharmaceuticals, Snap, Sundial Growers, Bitnile, or Cyngn?
22 Apr 22
Opinion, Press Releases
NEW YORK, April 22, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for VLON, SNAP, SNDL, NILE, and CYN.
Vallon Pharmaceuticals Announces Topline Results of its Pivotal SEAL Study for Lead Program, ADAIR, for the Treatment of ADHD
21 Mar 22
Press Releases
– Study did not meet primary endpoint of significant reduction in Emax Drug Liking for ADAIR vs reference dextroamphetamine, although a trend in favor of ADAIR was observed (p=0.16) – All pharmacodynamic
Vallon Pharmaceuticals Announces Appointment of Meenu Karson to Board of Directors
28 Feb 22
Press Releases
Global biopharmaceutical industry senior executive with over 15 years of operational leadership with transactional and capital markets experience spanning both private and public large pharma and small biotech companies
Vallon Pharmaceuticals Announces Issuance of U.S. Patent Covering ADAIR for the Treatment of Cognitive Impairment Associated with COVID-19
28 Feb 22
Press Releases
- Company in ongoing discussions with a major academic research center for design and execution of proof-of-concept study evaluating ADAIR for the treatment of cognitive impairment associated with COVID-19